The new findings clarify the Type 2 diabetes risks associated with statins, but the debate over who should be taking the …
Crestor
FDA Warns Statin Users of Memory Loss and Diabetes Risks
The Food and Drug Administration (FDA) added new safety warnings to cholesterol-reducing statin drugs on Wednesday, noting increased risks of Type 2 diabetes and memory loss for patients who take the medications.
Are Cholesterol Drugs a Good Idea for Healthy People?
In February, the U.S. Food and Drug Administration approved new criteria for the prescribing of the cholesterol-lowering drug (statin) Crestor (rosuvastatin calcium) to include people at low risk for heart attack or stroke — …